Click here to view the United Healthcare (UHC) Medical Policy Updates » March 2025 United…
BCBS Alabama Medical Policy Updates – April 2018
Click here to view the Blue Cross Blue Shield Alabama Medical Policy Updates »
March 2018 Medical Policy Updates:
- Peroral Endoscopic Myotomy for Treatment of Esophageal Achalasia and Refractory Gastroparesis
- Hematopoietic Cell Transplantation for Solid Tumors of Childhood
- Genetic Testing for Marfan Syndrome and Related Disorders
- Prophylactic Oophorectomy
- Retinal Telescreening for Diabetic Retinopathy
- Amniotic Membrane and Amniotic Fluid
- Whole Exome and Whole Genome Sequencing for Diagnosis of Genetic Disorders
- Corneal Collagen Cross-Linking
- Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia
- Artificial Pancreas Device Systems
- Expanded Molecular Panel Testing of Cancers to Identify Targeted Therapies
- Transesophageal Endoscopic Therapies for Gastroesophageal Reflux Disease-GERD
- Implantable Sinus Stents and Drug-Eluting Implants for Postoperative Use Following Endoscopic Sinus Surgery and for Recurrent Sinus Disease
- Ultrasounds in Maternity Care
- Treatment of Tinnitus
- Bio-Engineered Skin and Soft Tissue Substitutes
- Levonorgestrel-releasing Intrauterine System
- High Risk Maternity Care
- Stem-cell Therapy for Peripheral Arterial Disease
- Gynecomastia Surgery
- Electrical Stimulation in the Treatment of Arthritis
- Cognitive-Neurobehavioral-Neurorestorative Rehabilitation
- Genetic Testing for Hereditary Pancreatitis
- Viscocanalostomy and Canaloplasty
- Adjustable Cranial Orthoses for Positional Plagiocephaly and Craniosynostoses
- Heating and Cooling Devices Used in the Home Setting
- Balloon Dilation of the Eustachian Tube
- Novel Biomarkers in Risk Assessment and Management of Cardiovascular Disease
- Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome
- Microarray-Based Gene Expression Profile Testing for Multiple Myeloma Risk Stratification
- Gene Expression-Based Assays Testing for Cancers of Unknown Primary
- Postsurgical Home Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis
- Intracellular Micronutrient Analysis
- Urinary Tumor Markers for Bladder Cancer
- Genetic Testing for Familial Cutaneous Malignant Melanoma
- Genetic Testing for CHARGE Syndrome
- Surgical Management of Morbid Obesity
- Ophthalmologic Techniques for Evaluating Glaucoma
- Amniotic Membrane Transplantation for the Ocular Surface
- Hippotherapy
- Genetic Testing for Heterozygous Familial Hypercholesterolemia
- Gene Expression Profiling for Uveal Melanoma
- Genetic Testing for Rett Syndrome
- Natural Orifice Transluminal Endoscopic Surgery
- Magnetic Resonance-Guided Focused Ultrasound
- Hematopoietic Cell Transplantation in the Treatment of Germ-Cell Tumors
- Surgical Interruption of Pelvic Nerve Pathways for Primary and Secondary Dysmenorrhea
- Injectable Progesterone Therapy as a Technique to Reduce Preterm Birth in High-Risk Pregnancies
- Prostatic Urethral Lift
- Photodynamic Therapy for Choroidal Neovascularization
- Retinal Prosthesis
- Ocriplasmin for Symptomatic Vitreomacular Adhesion
- BCR-ABL1 Testing in Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia
- Implantable Bone Conduction and Bone-Anchored Hearing Aids
- Semi-Implantable and Fully Implantable Middle Ear Hearing Aids
- Cochlear Implants
- Management of Varicose Veins
- Lymphedema Pumps – Pneumatic Compression Devices
- Gene Expression Testing in the Evaluation of Patients With Stable Ischemic Heart Disease
- Laboratory and Genetic Testing for Use of 5-Fluorouracil in Patients with Cancer
- Functional Neuromuscular Electrical Stimulation
- Hematopoietic Cell Transplantation for Waldenstrom Macroglobulinemia
- Hematopoietic Cell Transplantation for Hodgkin Lymphoma
- Biophysical Fetal Profile
- Polysomnography for Respiratory Sleep Disorders Testing
- Continuous Passive Motion in the Home Setting
- Sensory Integration Therapy and Auditory Integration Therapy
- First-Trimester Detection of Down Syndrome Using Fetal Ultrasound Markers Combined with Maternal Serum Assessment
- Implantation of Intrastromal Corneal Ring Segments
- Vagus Nerve Blocking Therapy for Treatment of Obesity
Click here to view the Blue Cross Blue Shield Alabama Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While Payers typically update medical policies annually, there are many reasons why a Payer might review or update a policy. When reviews occur out of cycle, they may go unnoticed. Policy Alerts keeps you informed of upcoming and unexpected coverage changes affecting your product. Quickly understanding the changes Payers make can help you adjust reimbursement strategies impacting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on Payer decisions in real-time. Whenever changes occur, email notifications containing a summary of those changes are delivered to your inbox. Clients can access detailed coverage reports and medical policies on the interactive Dashboard portal. Save time and keep focused on the important Payer medical policy reviews and coverage decisions affecting your product!
Policy Alerts takes a client-focused hands-on approach and works hard to provide our customers with helpful insights and actionable analytics over raw data. We understand what our clients need and we are dedicated to making sure we provide timely, accurate and always up-to-date reports that can be used to implement and support a successful reimbursement strategy.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
